Several studies have assessed the relationship between blood pressure (BP) and polymorphisms within the genes encoding angiotensinogen (AGT), angiotensin II type 1 receptor (AT1R) and angiotensin-converting enzyme (ACE). However, considering the relatively large discrepancy in frequency and impact of these variants between ethnic groups and populations, still unavailable data from Algerian population are needed.
Objective
Our purpose is to evaluate the association between the AGT M235T, AT1R +1166A/C and ACE I/D polymorphisms and variations in systolic (SBP), diastolic (DBP) and pulse pressure (PP) values.
Methods
The associations with BP were assessed in a representative sample of 115 male subjects free of coronary heart disease (CHD). The AGT M235T, AT1R +1166A/C and ACE I/D polymorphisms were determined by PCR-ASO and PCR-RFLP analysis, respectively.
Results
We showed no associations between the AGT M235T, AT1R +1166A/C nor the ACE I/D polymorphisms with variations in BP values. However, concerning the ACE I/D polymorphism, subjects carrying the ACE I allele tended to have higher SBP (+4.1 mmHg) and PP values (+3.2 mmHg) than DD subjects (adjusted p = 0.087 and p = 0.102, respectively).
Conclusion
The ACE I/D polymorphism needs further investigation in a larger Algerian study, especially concerning its putative impact on SBP and PP.
SeemanTMendesdeLeonCBerkmanL. Risk factors for coronary heart disease among older men and women: A prospective study of community-dwelling elderly. Am J Epidemiol1993; 138: 1037–1049.
3.
SealeyJFJamesGDLaraghJH.The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potasium homeostasis. In: LaraghJHBrennerBM (eds) Hypertension: Pathophysiology, diagnosis and management, vol 2. New York, NY, USA: Raven Press, 1995, pp.1763–1796.
4.
DzauVJ.Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med1993; 153: 937–942.
5.
UrataHNishimuraHGantenN.Chymase-dependent angiotensin II forming system in humans. Am J hypertens1996; 9: 277–284.
6.
AziziMGuyeneTTChatellierG. Additive effects of losartan and enalapril on blood pressure and plasma active renin. Hypertension1997; 29: 634–640.
7.
PfefferMABraunwaldEMoyéLA. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med1992; 327: 669–677.
8.
LewisEJHunsickerLGBainRP. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med1993; 330: 152.
StaessenJAWangJGGinocchioG. The deletion/insertion polymorphism of the converting enzyme and cardiovascular-renal risk. J Hypertens1997; 15: 1579–1592.
11.
Médiène-BenchekorSBrousseauTRichardF. Blood lipid concentrations and risk of myocardial infarction. Lancet2001; 358: 1064–1065.
12.
ParraHJArveilerDEvansEA. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. Arterioscler Thromb Vasc Biol1992; 12: 701–707.
13.
LindpaintnerKPfefferMAKreutzR. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med1995; 332: 706–711.
14.
Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J1998; 19: 1434–1503.
15.
WangJGSteassenJA.Genetic polymorphisms in the renin-angiotensin system: Relevance for susceptibility to cardiovascular disease. Eur J Pharmacol2000; 410: 289–302.
16.
GardemannANguyenQDHummeJ. Angiotensin II type 1 receptor A1166C gene polymorphism. Absence of an association with the risk of coronary artery disease and myocardial infarction and of a synergistic effect with angiotensin-converting enzyme gene polymorphism on the risk of these diseases. Eur Heart J1998; 19: 1657–1665.
17.
HindorffLAHeckbertSRTracyR. Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: Relation to blood pressure, ethnicity, and cardiovascular events. Am J Hypertens2002; 15: 1050–1056.
18.
AokiSMukaeSItohS. Genetic background in patients with acute myocardial infarction. Jpn Heart J2001; 42: 15–28.
19.
BayoumiRASimsekMYahyaTM. Insertion-deletion polymorphism in the angiotensin-converting enzyme (ACE) gene among Sudanese, Somalis, Emiratis, and Omanis. Hum Biol2006; 78: 103–108.
20.
SalemAHBatzerMA.High frequency of the D allele of the angiotensin-converting enzyme gene in Arabic populations. BMC Res Notes2009; 2: 1–5.
21.
MahjoubSMehriSBousaadaR. Association of ACE I/D polymorphism in Tunisian patients with dilated cardiomyopathy. J Renin Angiotensin Aldosterone Syst2010; 11: 187–191.
22.
BautistaLVargasCIOrósteguiM. Population-based case-control study of renin-angiotensin system genes polymorphisms and hypertension among Hispanics. Hypertens Res2008; 31: 401–408.
23.
TakamiSKatsuyaTRakugiH. Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension. Am J Hypertens1998; 11: 316–321.
24.
KatoNSugiyamaTMoritaH. Angiotensinogen gene and essential hypertension in the Japanese: Extensive association study and meta-analysis on six reported studies. J Hypertens1999; 17: 757–763.
25.
KrizanováOObdrzálkováDPolákováH. Molecular variants of the renin-angiotensin system components in the Slovak population. Physiol Res1997; 46: 357–361.
26.
KunzRKreutzRBeigeJ. Association between the angiotensinogen 235T-variant and essential hypertension in whites: A systematic review and methodological appraisal. Hypertension1997; 30: 1331–1337.
27.
AgachanBIsbirTYilmazH. Angiotensin converting enzyme I/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients. Exp Mol Med2003; 35: 545–549.
28.
van den BornBJvan MontfransGAUitterlindenAG. The M235T polymorphism in the angiotensinogen gene is associated with the risk of malignant hypertension in white patients. J Hypertens2007; 25: 2227–2233.
29.
MondryALohMLiuP.Polymorphisms of the insertion/deletion ACE and M235T AGT genes and hypertension: Surprising new findings and meta-analysis of data. BMC Nephrol2005; 6: 1–11.
30.
ZhangXErdmannJRegitz-ZagrosekV. Evaluation of three polymorphisms in the promoter region of the angiotensin II type 1 receptor gene. J Hypertens2000; 18: 267–272.
31.
WangWYZeeRYMorrisBJ. Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Clin Genet1997; 51: 31–34.
32.
BarbeauPKulharyaAHarshfieldG. Association between angiotensin II type I receptor polymorphism and resting hemodynamics in black and white youth. Ethn Dis2002; 12: S1–68–71.
33.
HenskensLHSpieringWStoffersHE. Effects of ACE I/D and AT1R-A1166C polymorphisms on blood pressure in a healthy normotensive primary care population: First results of the Hippocates study. J Hypertens2003; 21: 81–86.
34.
ReichHDuncanJAWeinsteinJ. Interactions between gender and the angiotensin type 1 receptor gene polymorphism. Kidney Int2003; 63: 1443–1449.
35.
FrossardPMHillSHElshahatYI. Associations of angiotensinogen gene mutations with hypertension and myocardial infarction in a gulf population. Clin Genet1998; 54: 285–293.
36.
PochEdeLaSierraAGonzález-NúñezD. Genetic polymorphisms of the renin-angiotensin system and essential hypertension [in Spanish]. Med Clin (Barc)2007; 118: 575–579.
37.
NápolesOCCastellanosMSLealL. A polymorphism study in a Cuban hypertensive population. Clin Chim Acta2007; 378: 112–116.
38.
SagnellaGARothwellMJOnipinlaAK. A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism: Relationships with gender, hypertension and impaired glucose metabolism. J Hypertens1999; 17: 657–664.
39.
MorshedMKhanHAkhteruzzamanH.Association between angiotensin I-converting enzyme gene polymorphism and hypertension in selected individuals of the Bangladeshi population. J Biochem Mol Biol2002; 33: 251–254.
